問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
廖家德
下載
2022-08-01 - 2023-08-14
Condition/Disease
Test Drug
Participate Sites2Sites
Recruiting2Sites
2022-05-02 - 2026-09-30
xxxxxx
Sibeprenlimab (VIS649) Sibeprenlimab (VIS649)
Participate Sites6Sites
Recruiting6Sites
2023-12-28 - 2027-02-28
Chronic Kidney Disease on Dialysis
Efepoetin alfa (GX-E4)
Participate Sites5Sites
Recruiting5Sites
2018-03-20 - 2024-03-31
Acute Coronary Syndrome
CSL112
Participate Sites11Sites
Recruiting7Sites
Terminated3Sites
未分科
2021-07-01 - 2023-02-01
Recruiting4Sites
Terminated2Sites
2020-11-30 - 2022-03-28
Membranous Nephropathy
MOR202
2023-03-01 - 2027-02-28
Participate Sites17Sites
Recruiting17Sites
2022-04-01 - 2024-12-31
Not yet recruiting2Sites
Recruiting3Sites
2021-05-31 - 2023-03-14
Participate Sites4Sites
2022-01-05 - 2026-09-19
Not yet recruiting1Sites
全部
